NDC 65162-844

Capecitabine

Capecitabine

Capecitabine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Capecitabine.

Product ID65162-844_01fee139-bdbe-4f2b-af73-acf8131e264e
NDC65162-844
Product TypeHuman Prescription Drug
Proprietary NameCapecitabine
Generic NameCapecitabine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2017-03-10
Marketing CategoryANDA / ANDA
Application NumberANDA204741
Labeler NameAmneal Pharmaceuticals LLC
Substance NameCAPECITABINE
Active Ingredient Strength500 mg/1
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 65162-844-06

60 TABLET in 1 BOTTLE (65162-844-06)
Marketing Start Date2017-03-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65162-844-06 [65162084406]

Capecitabine TABLET
Marketing CategoryANDA
Application NumberANDA204741
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-03-10

NDC 65162-844-16 [65162084416]

Capecitabine TABLET
Marketing CategoryANDA
Application NumberANDA204741
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-03-10

NDC 65162-844-50 [65162084450]

Capecitabine TABLET
Marketing CategoryANDA
Application NumberANDA204741
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-03-10

Drug Details

Pharmacological Class

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]

Medicade Reported Pricing

65162084416 CAPECITABINE 500 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Capecitabine" or generic name "Capecitabine"

NDCBrand NameGeneric Name
0054-0271CapecitabineCapecitabine
0054-0272CapecitabineCapecitabine
0093-7473CapecitabineCapecitabine
0093-7474CapecitabineCapecitabine
0378-2511Capecitabinecapecitabine
0378-2512Capecitabinecapecitabine
16714-467CAPECITABINECAPECITABINE
67877-458CapecitabineCapecitabine
67877-459CapecitabineCapecitabine
69097-949CapecitabineCapecitabine
69097-948CapecitabineCapecitabine
69539-019CapecitabineCapecitabine
69539-020CapecitabineCapecitabine
72205-006CapecitabineCapecitabine
72205-007CapecitabineCapecitabine
16714-468CAPECITABINECAPECITABINE
16729-072CAPECITABINECAPECITABINE
16729-073CAPECITABINECAPECITABINE
42291-167CapecitabineCapecitabine
50268-154CapecitabineCapecitabine
51079-510CapecitabineCapecitabine
51407-095CapecitabineCapecitabine
51407-096CapecitabineCapecitabine
59651-204CapecitabineCapecitabine
59651-205CapecitabineCapecitabine
60687-149CapecitabineCapecitabine
63759-3000CapecitabineCapecitabine
63759-3001CapecitabineCapecitabine
64980-277CapecitabineCapecitabine
64980-276CapecitabineCapecitabine
65162-844CapecitabineCapecitabine
65162-843CapecitabineCapecitabine
0004-1100Xelodacapecitabine
0004-1101Xelodacapecitabine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.